⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3097804 | 0.73 | — | — | |
| SCHEMBL11583876 | 0.72 | — | — | |
| SCHEMBL728388 | 0.70 | — | — | |
| SCHEMBL313208 | 0.70 | — | — | |
| SCHEMBL14127604 | 0.70 | — | — | |
| SCHEMBL23710645 | 0.68 | — | — | |
| SCHEMBL1038664 | 0.67 | — | — | |
| SCHEMBL5439701 | 0.67 | — | — | |
| SCHEMBL1040886 | 0.67 | — | — | |
| SCHEMBL1647946 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2585449-A1 | PROCESS FOR THE PREPARATION OF 5-SUBSTITUTED 1-ALKYLTETRAZOLYL OXIME DERIVATIVES | Bayer Intellectual Property GmbH (DE) | 2013-05-01 | — | — | EP | disclosed |
| WO-2012000918-A1 | PROCESS FOR THE PREPARATION OF 5-SUBSTITUTED 1-ALKYLTETRAZOLYL OXIME DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2012-01-05 | — | — | WO | disclosed |
| EP-2089023-A2 | METHODS OF TREATING NEUROPATHIC PAIN WITH AGONISTS OF PPAR-GAMMA | Aestus Therapeutics, Inc. (US) | 2009-08-19 | — | — | EP | disclosed |
| EP-2089017-A2 | METHODS OF TREATING NEUROPATHIC PAIN BY MODULATION OF GLYCOGENOLYSIS OR GLYCOLYSIS PATHWAYS | Aestus Therapeutics, Inc. (US) | 2009-08-19 | — | — | EP | disclosed |
| WO-2008063842-A2 | METHODS OF TREATING NEUROPATHIC PAIN WITH AGONISTS OF PPAR-GAMMA | AESTUS THERAPEUTICS, INC. (US) | 2008-05-29 | — | — | WO | disclosed |
| WO-2008057933-A2 | METHODS OF TREATING NEUROPATHIC PAIN BY MODULATION OF GLYCOGENOLYSIS OR GLYCOLYSIS PATHWAYS | AESTUS THERAPEUTICS, INC. (US) | 2008-05-15 | — | — | WO | disclosed |